Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Buzz on the Bullboards: A recap of recent activity and stocks in focus

Last week witnessed a flurry of stock activity on Bay Street in Toronto and Wall Street in New York, as investors grappled with market volatility and shifting dynamics. After a major sell-off, markets have been on edge, closely monitoring corporate earnings and other key ...

The end of the global economy

The Trump administration has just granted its Commerce Department sweeping powers to slap tariffs on countries it decides are manipulating their currencies to the detriment of the United States and its exporting companies. For some this will come as news; at AOTH, it is c...

Theralase is raising up to $5.3M to complete bladder cancer study

Theralase Technologies is announcing a brokered financing raise for up to C$5.3 million Proceeds of the financing will be used to further the Phase II Non-Muscle Invasive Bladder Cancer (NMIBC) clinical study Ruvidar is designed to destroy solid core tum...

Pharmaceutical company treats bladder cancer with new tech

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Theralase Technologies Inc. (TSXV:TLT) , a clinical-stage pharmaceutical company, is currently developing an innovative, research-backed technology for the ...

Disruptive Technology Poised to Deliver Significant Advancement in Bladder Cancer Detection

Chris Temple, editor and publisher of The National Investor, explains why he recommends this small-cap as a Buy. Imagin Medical's disruptive technology is poised to deliver the most significant advancement in bladder cancer detection and removal in decades , ma...

Palladium Surges above $2,400. Is It Sustainable?

A new day, a new record in palladium! Is there any stopping it from reaching another high? What’s next in store for the white metal? If you thought gold had a good year, you were wrong. OK, maybe not wrong, but palladium enjoyed larger gains . Just lo...

Is the Stock Market Out of the Woods Now?

Having opened with a sizable gap, stocks scored sizable gains yesterday. The reversal higher makes one think that we’ve seen a bullish turn. And the short-term outlook has certainly turned more to the bullish side of the spectrum. Let’s assess w...

Technical Analyst Update on Black Tusk Resources

Technical analyst Clive Maund charts the explorer and discusses recent trading in the stock. Although our buying towards the end of May didn't succeed in triggering a breakout by Black Tusk Resources Inc. (TUSK:CSE; BTKRF:OTCMKTS; 0NB:FSE) , it rose a bit and it...

2020 – A Close Look At What To Expect

Quite a bit has changed in the global markets and future expectations over the past 4+ weeks. Q4 2019 ended with a bang. US/China Trade Deal, US signing the USMCA Continental Free Trade Agreement, BREXIT and now the Wuhan Virus. On top of all of that, we've learned that German...

S&P 500 Grind Higher Goes On, Regardless of Daily Setbacks

The runup to yesterday’s US open and the regular session’s trading confirmed my call that stocks would break above the key resistances. And they did effortlessly overcome the upper border of March’s gap and the 61.8% Fibonacci re...
1 2 3 4 5 6 7 8 9 10 ...